×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Upper GI Series Market Share

ID: MRFR/Pharma/0330-HCR
146 Pages
Kinjoll Dey
October 2025

upper GI series market research report, by test types (the standard barium upper GI series & double-contrast upper GI series), by type of imaging material (barium swallow, barium meal, barium follow-through), by application (esophageal reflux, esophageal varices, ulcers, hiatal hernias & others), by end users (hospitals, clinics & laboratories and other) -Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Upper GI Series Market Infographic
Purchase Options

Market Share

Upper GI Series Market Share Analysis

The Upper Gastrointestinal Series market revolves around diagnostic procedures that examine the upper digestive tract using X-ray technology. With a focus on conditions like ulcers, reflux, and swallowing disorders, strategic positioning is crucial in this competitive medical imaging landscape. Considering the fast pace of contemporary world, staying in the cutting-edge of the technologies becomes imperative. Utilization of modern imaging technology and adoption of contemporary approaches result in perfect accuracy in diagnosis, building the company brand, which in turn, attracts healthcare providers looking for first-rate services and makes the company a leader in the market for UGI devices. We strive to build strong networks with healthcare providers at all levels which is a perquisite. The features of training programs that offer online training and educational resources with technical support help to build customer loyalty. The cooperation not only offers a tremendous increase in the sales volume but also effectively puts machines in use which is good for the both sides. Marketing should aim at reaching specialists, including gastroenterologists and radiologists, by providing them with targeted information, oncology sessions, and strong evidence via case studies. The focus should be on highlighting the unique advantages of UGI procedures that the practice and the patients can get from it, which in turn leads to the attraction of wizened medical experts with the market share of their specific market segments endorsed. Mainly placement of the UGI services at the patients’ side is an essential point. Achieving low radiation levels for the procedure, procurement of the highest amenities during the process, encompassed with clear communication is some of the major factors that create wonderful patient experiences. Content customers can indeed influence the selection of the healthcare provider and as a result, market share, when they do this. Facilitating electronic health record (EHR) data flow interoperability increases the possibility of delivering a standard health care service. Organizations that take those steps become more attractive to health institutions that aim to deliver more consolidated and smooth diagnosis outcomes. Healthcare settings could be considered value-based service providers as cost-effective products and services boost their strategic move. Offering customers the value they are seeking with pricing strategies and finding out how to apply for payment can help to increase these products demand which in turn will pull market shares towards these products.

Offering ongoing training programs for healthcare professionals ensures optimal utilization of UGI equipment. This commitment to education not only enhances the reputation of the company but also strengthens relationships with healthcare providers, contributing to market share growth. Educating patients about the importance of UGI procedures and the early detection of gastrointestinal conditions is crucial. Companies that invest in patient education initiatives, both online and offline, contribute to raising awareness, fostering a positive brand image, and potentially increasing market share.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Leave a Comment

FAQs

What is the projected market valuation for the Upper GI Series Market in 2035?

The projected market valuation for the Upper GI Series Market in 2035 is 4.703 USD Billion.

What was the overall market valuation of the Upper GI Series Market in 2024?

The overall market valuation of the Upper GI Series Market in 2024 was 2.741 USD Billion.

What is the expected CAGR for the Upper GI Series Market during the forecast period 2025 - 2035?

The expected CAGR for the Upper GI Series Market during the forecast period 2025 - 2035 is 5.03%.

Which companies are considered key players in the Upper GI Series Market?

Key players in the Upper GI Series Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.

What are the main segments of the Upper GI Series Market?

The main segments of the Upper GI Series Market include Test Type, Imaging Material, Application, and End-Users.

Market Summary

As per MRFR analysis, the Upper GI Series Market Size was estimated at 2.741 USD Billion in 2024. The Upper GI Series industry is projected to grow from 2.879 USD Billion in 2025 to 4.703 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.03 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Upper GI Series Market is poised for growth driven by technological advancements and increasing health awareness.

  • Technological advancements in imaging are enhancing the accuracy and efficiency of Upper GI Series Market procedures.
  • North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for Upper GI Series Market.
  • The Upper Barium Series segment holds the largest market share, whereas the Double-Contrast Upper GI Series Market is witnessing the fastest growth.
  • Rising incidence of gastrointestinal disorders and increased focus on preventive healthcare are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 2.741 (USD Billion)
2035 Market Size 4.703 (USD Billion)
CAGR (2025 - 2035) 5.03%
Largest Regional Market Share in 2024 North America

Major Players

<p>GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Hologic, Inc. (US), Medtronic (US), Boston Scientific Corporation (US), Bracco Imaging S.p.A. (IT)</p>

Market Trends

The Upper GI Series Market is currently experiencing a notable evolution, driven by advancements in imaging technologies and an increasing emphasis on early diagnosis of gastrointestinal disorders. This market encompasses a range of diagnostic procedures that utilize radiographic techniques to visualize the upper gastrointestinal tract, including the esophagus, stomach, and duodenum. As healthcare providers strive to enhance patient outcomes, the demand for non-invasive and efficient diagnostic methods appears to be on the rise. Furthermore, the integration of digital imaging and telemedicine solutions is likely to reshape the landscape of gastrointestinal diagnostics, making it more accessible to a broader population. In addition to technological advancements, the Upper GI Series Market is influenced by changing demographics and rising awareness regarding gastrointestinal health. An aging population, coupled with lifestyle changes, has led to an increase in gastrointestinal disorders, thereby propelling the need for effective diagnostic tools. Moreover, educational initiatives aimed at promoting awareness of gastrointestinal health may further stimulate market growth. As the healthcare sector continues to evolve, the Upper GI Series Market seems poised for expansion, with potential opportunities for innovation and improved patient care in the coming years.

Technological Advancements in Imaging

Recent innovations in imaging technologies are transforming the Upper GI Series Market. Enhanced imaging techniques, such as digital radiography and fluoroscopy, are improving diagnostic accuracy and patient experience. These advancements facilitate quicker and more precise assessments of gastrointestinal conditions, thereby increasing the appeal of upper GI series procedures.

Growing Demand for Non-Invasive Procedures

There is a rising preference for non-invasive diagnostic methods within the Upper GI Series Market. Patients and healthcare providers alike are gravitating towards procedures that minimize discomfort and risk. This trend is likely to drive the adoption of upper GI series as a preferred diagnostic tool for various gastrointestinal disorders.

Increased Awareness of Gastrointestinal Health

The Upper GI Series Market is benefiting from heightened awareness regarding gastrointestinal health. Educational campaigns and public health initiatives are encouraging individuals to seek timely diagnosis and treatment for gastrointestinal issues. This growing consciousness may lead to an uptick in the utilization of upper GI series as a vital diagnostic procedure.

Upper GI Series Market Market Drivers

Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare is likely to propel the Upper GI Series Market forward. As more individuals prioritize regular health screenings and early detection of gastrointestinal issues, the demand for diagnostic procedures such as the Upper GI Series Market is expected to rise. This trend is supported by public health campaigns that promote awareness of gastrointestinal health and the importance of early intervention. Consequently, healthcare providers are increasingly recommending upper GI imaging as part of routine check-ups, thereby expanding the market. The Upper GI Series Market stands to benefit from this shift towards preventive care, as patients seek proactive measures to maintain their health.

Aging Population and Associated Health Issues

The aging population presents a significant driver for the Upper GI Series Market. As individuals age, they become more susceptible to various gastrointestinal disorders, necessitating regular monitoring and diagnostic evaluations. The demographic shift towards an older population is accompanied by an increase in conditions such as dysphagia and gastrointestinal cancers, which require effective imaging solutions for diagnosis. This demographic trend suggests a sustained demand for upper GI imaging services, as healthcare systems adapt to the needs of an aging populace. The Upper GI Series Market is thus positioned to grow in response to the healthcare demands of older adults, who require comprehensive diagnostic assessments.

Rising Incidence of Gastrointestinal Disorders

The increasing prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers, appears to be a primary driver for the Upper GI Series Market. According to recent health statistics, the incidence of these conditions has been on the rise, leading to a greater demand for diagnostic imaging solutions. As healthcare providers seek effective methods to diagnose and monitor these disorders, the Upper GI Series Market becomes a preferred choice due to its ability to provide detailed images of the upper gastrointestinal tract. This trend indicates a growing market potential, as more patients require accurate assessments for timely treatment. The Upper GI Series Market is thus likely to expand in response to this increasing need for diagnostic clarity in gastrointestinal health.

Technological Innovations in Imaging Techniques

Technological advancements in imaging techniques are significantly influencing the Upper GI Series Market. Innovations such as digital radiography and improved fluoroscopy systems enhance the quality and efficiency of upper gastrointestinal imaging. These advancements not only improve diagnostic accuracy but also reduce patient exposure to radiation, addressing safety concerns. The integration of artificial intelligence in image analysis further streamlines the diagnostic process, potentially leading to quicker and more reliable results. As healthcare facilities adopt these cutting-edge technologies, the Upper GI Series Market is expected to experience substantial growth, driven by the demand for enhanced imaging capabilities and improved patient outcomes.

Rising Healthcare Expenditure and Access to Services

The increase in healthcare expenditure across various regions is likely to enhance access to diagnostic services, including the Upper GI Series Market. As governments and private sectors invest more in healthcare infrastructure, the availability of advanced imaging technologies becomes more widespread. This investment facilitates better access to diagnostic procedures for a larger segment of the population, particularly in underserved areas. Furthermore, as patients gain better access to healthcare services, the demand for upper GI imaging is expected to rise, driven by the need for accurate diagnosis and treatment planning. The Upper GI Series Market is thus poised for growth, supported by the overall increase in healthcare spending and improved service accessibility.

Market Segment Insights

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for Upper GI Series Market, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of gastrointestinal disorders, and rising demand for diagnostic imaging. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The United States leads the market, followed by Canada, with significant contributions from key players such as GE Healthcare and Hologic, Inc. The competitive landscape is characterized by continuous innovation and strategic partnerships among major companies, enhancing product offerings and market reach. The presence of established healthcare systems facilitates the adoption of advanced imaging technologies, solidifying North America's position as a market leader.

Europe : Emerging Market Dynamics

Europe is the second-largest market for Upper GI Series Market, accounting for approximately 30% of the global share. The region's growth is fueled by increasing healthcare expenditure, a rising geriatric population, and advancements in imaging technologies. Regulatory frameworks, such as the EU Medical Device Regulation, ensure high standards for medical devices, promoting market growth. Leading countries include Germany, France, and the UK, where significant investments in healthcare infrastructure are observed. Key players like Siemens Healthineers and Philips Healthcare are actively involved in enhancing diagnostic capabilities. The competitive landscape is marked by collaborations and innovations aimed at improving patient outcomes and operational efficiency in healthcare settings.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is witnessing rapid growth in the Upper GI Series Market, holding about 20% of the global share. The region's expansion is driven by increasing healthcare investments, a growing population, and rising awareness of gastrointestinal health. Countries like China and India are experiencing significant demand for advanced diagnostic solutions, supported by government initiatives to improve healthcare access. China is the largest market in the region, followed by Japan and India, where key players like Canon Medical Systems and Fujifilm Holdings are enhancing their market presence. The competitive landscape is evolving, with local manufacturers emerging alongside established global players, fostering innovation and affordability in diagnostic imaging technologies.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the Upper GI Series Market, holding around 5% of the global share. The growth is driven by increasing healthcare investments, rising prevalence of gastrointestinal diseases, and a growing focus on improving healthcare infrastructure. Government initiatives aimed at enhancing healthcare access and quality are also contributing to market expansion. Leading countries include South Africa and the UAE, where investments in healthcare facilities are on the rise. The competitive landscape is characterized by a mix of local and international players, with companies like Bracco Imaging and Boston Scientific expanding their footprint. The region presents significant opportunities for growth, particularly in enhancing diagnostic capabilities and patient care.

Key Companies in the Upper GI Series Market market include

Industry Developments

EISAI Co. Ltd on its collaboration with AJINOMOTO Co. inc led to the formation of various gastrointestinal techniques. They also launched certain gastro products which increased the upper GI series market value. GE healthcare a renounceable United States company launched an effective visualization effective methods for

Future Outlook

Upper GI Series Market Future Outlook

<p>The Upper GI Series Market is projected to grow at a 5.03% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of gastrointestinal disorders, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of AI-driven diagnostic imaging tools</p>
  • <p>Expansion of telehealth services for remote consultations</p>
  • <p>Investment in portable imaging devices for outpatient settings</p>

<p>By 2035, the Upper GI Series Market is expected to achieve robust growth and enhanced service delivery.</p>

Market Segmentation

Upper GI Series Market End-Users Outlook

  • Medical Centers
  • Clinics

Upper GI Series Market Test Type Outlook

  • Upper Barium Series
  • Double-Contrast Upper GI Series

Upper GI Series Market Application Outlook

  • Esophageal Reflux
  • Hiatal Hernias
  • Ulcers

Upper GI Series Market Imaging Material Outlook

  • Barium Swallow
  • Barium Meal
  • Barium Follow-Through

Report Scope

MARKET SIZE 20242.741(USD Billion)
MARKET SIZE 20252.879(USD Billion)
MARKET SIZE 20354.703(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.03% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesIntegration of advanced imaging technologies enhances diagnostic accuracy in the Upper GI Series Market.
Key Market DynamicsTechnological advancements and regulatory changes are reshaping the competitive landscape of the Upper GI Series Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation for the Upper GI Series Market in 2035?

The projected market valuation for the Upper GI Series Market in 2035 is 4.703 USD Billion.

What was the overall market valuation of the Upper GI Series Market in 2024?

The overall market valuation of the Upper GI Series Market in 2024 was 2.741 USD Billion.

What is the expected CAGR for the Upper GI Series Market during the forecast period 2025 - 2035?

The expected CAGR for the Upper GI Series Market during the forecast period 2025 - 2035 is 5.03%.

Which companies are considered key players in the Upper GI Series Market?

Key players in the Upper GI Series Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.

What are the main segments of the Upper GI Series Market?

The main segments of the Upper GI Series Market include Test Type, Imaging Material, Application, and End-Users.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Test Type (USD Billion)
      1. Upper Barium Series
      2. Double-Contrast Upper GI Series
    2. Healthcare, BY Imaging Material (USD Billion)
      1. Barium Swallow
      2. Barium Meal
      3. Barium Follow-Through
    3. Healthcare, BY Application (USD Billion)
      1. Esophageal Reflux
      2. Hiatal Hernias
      3. Ulcers
    4. Healthcare, BY End-Users (USD Billion)
      1. Medical Centers
      2. Clinics
    5. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. GE Healthcare (US)
      2. Siemens Healthineers (DE)
      3. Philips Healthcare (NL)
      4. Canon Medical Systems (JP)
      5. Fujifilm Holdings Corporation (JP)
      6. Hologic, Inc. (US)
      7. Medtronic (US)
      8. Boston Scientific Corporation (US)
      9. Bracco Imaging S.p.A. (IT)
    3. Appendix
      1. References
      2. Related Reports
  6. LIST OF FIGURES
    1. MARKET SYNOPSIS
    2. NORTH AMERICA MARKET ANALYSIS
    3. US MARKET ANALYSIS BY TEST TYPE
    4. US MARKET ANALYSIS BY IMAGING MATERIAL
    5. US MARKET ANALYSIS BY APPLICATION
    6. US MARKET ANALYSIS BY END-USERS
    7. CANADA MARKET ANALYSIS BY TEST TYPE
    8. CANADA MARKET ANALYSIS BY IMAGING MATERIAL
    9. CANADA MARKET ANALYSIS BY APPLICATION
    10. CANADA MARKET ANALYSIS BY END-USERS
    11. EUROPE MARKET ANALYSIS
    12. GERMANY MARKET ANALYSIS BY TEST TYPE
    13. GERMANY MARKET ANALYSIS BY IMAGING MATERIAL
    14. GERMANY MARKET ANALYSIS BY APPLICATION
    15. GERMANY MARKET ANALYSIS BY END-USERS
    16. UK MARKET ANALYSIS BY TEST TYPE
    17. UK MARKET ANALYSIS BY IMAGING MATERIAL
    18. UK MARKET ANALYSIS BY APPLICATION
    19. UK MARKET ANALYSIS BY END-USERS
    20. FRANCE MARKET ANALYSIS BY TEST TYPE
    21. FRANCE MARKET ANALYSIS BY IMAGING MATERIAL
    22. FRANCE MARKET ANALYSIS BY APPLICATION
    23. FRANCE MARKET ANALYSIS BY END-USERS
    24. RUSSIA MARKET ANALYSIS BY TEST TYPE
    25. RUSSIA MARKET ANALYSIS BY IMAGING MATERIAL
    26. RUSSIA MARKET ANALYSIS BY APPLICATION
    27. RUSSIA MARKET ANALYSIS BY END-USERS
    28. ITALY MARKET ANALYSIS BY TEST TYPE
    29. ITALY MARKET ANALYSIS BY IMAGING MATERIAL
    30. ITALY MARKET ANALYSIS BY APPLICATION
    31. ITALY MARKET ANALYSIS BY END-USERS
    32. SPAIN MARKET ANALYSIS BY TEST TYPE
    33. SPAIN MARKET ANALYSIS BY IMAGING MATERIAL
    34. SPAIN MARKET ANALYSIS BY APPLICATION
    35. SPAIN MARKET ANALYSIS BY END-USERS
    36. REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
    37. REST OF EUROPE MARKET ANALYSIS BY IMAGING MATERIAL
    38. REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    39. REST OF EUROPE MARKET ANALYSIS BY END-USERS
    40. APAC MARKET ANALYSIS
    41. CHINA MARKET ANALYSIS BY TEST TYPE
    42. CHINA MARKET ANALYSIS BY IMAGING MATERIAL
    43. CHINA MARKET ANALYSIS BY APPLICATION
    44. CHINA MARKET ANALYSIS BY END-USERS
    45. INDIA MARKET ANALYSIS BY TEST TYPE
    46. INDIA MARKET ANALYSIS BY IMAGING MATERIAL
    47. INDIA MARKET ANALYSIS BY APPLICATION
    48. INDIA MARKET ANALYSIS BY END-USERS
    49. JAPAN MARKET ANALYSIS BY TEST TYPE
    50. JAPAN MARKET ANALYSIS BY IMAGING MATERIAL
    51. JAPAN MARKET ANALYSIS BY APPLICATION
    52. JAPAN MARKET ANALYSIS BY END-USERS
    53. SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
    54. SOUTH KOREA MARKET ANALYSIS BY IMAGING MATERIAL
    55. SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    56. SOUTH KOREA MARKET ANALYSIS BY END-USERS
    57. MALAYSIA MARKET ANALYSIS BY TEST TYPE
    58. MALAYSIA MARKET ANALYSIS BY IMAGING MATERIAL
    59. MALAYSIA MARKET ANALYSIS BY APPLICATION
    60. MALAYSIA MARKET ANALYSIS BY END-USERS
    61. THAILAND MARKET ANALYSIS BY TEST TYPE
    62. THAILAND MARKET ANALYSIS BY IMAGING MATERIAL
    63. THAILAND MARKET ANALYSIS BY APPLICATION
    64. THAILAND MARKET ANALYSIS BY END-USERS
    65. INDONESIA MARKET ANALYSIS BY TEST TYPE
    66. INDONESIA MARKET ANALYSIS BY IMAGING MATERIAL
    67. INDONESIA MARKET ANALYSIS BY APPLICATION
    68. INDONESIA MARKET ANALYSIS BY END-USERS
    69. REST OF APAC MARKET ANALYSIS BY TEST TYPE
    70. REST OF APAC MARKET ANALYSIS BY IMAGING MATERIAL
    71. REST OF APAC MARKET ANALYSIS BY APPLICATION
    72. REST OF APAC MARKET ANALYSIS BY END-USERS
    73. SOUTH AMERICA MARKET ANALYSIS
    74. BRAZIL MARKET ANALYSIS BY TEST TYPE
    75. BRAZIL MARKET ANALYSIS BY IMAGING MATERIAL
    76. BRAZIL MARKET ANALYSIS BY APPLICATION
    77. BRAZIL MARKET ANALYSIS BY END-USERS
    78. MEXICO MARKET ANALYSIS BY TEST TYPE
    79. MEXICO MARKET ANALYSIS BY IMAGING MATERIAL
    80. MEXICO MARKET ANALYSIS BY APPLICATION
    81. MEXICO MARKET ANALYSIS BY END-USERS
    82. ARGENTINA MARKET ANALYSIS BY TEST TYPE
    83. ARGENTINA MARKET ANALYSIS BY IMAGING MATERIAL
    84. ARGENTINA MARKET ANALYSIS BY APPLICATION
    85. ARGENTINA MARKET ANALYSIS BY END-USERS
    86. REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
    87. REST OF SOUTH AMERICA MARKET ANALYSIS BY IMAGING MATERIAL
    88. REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USERS
    90. MEA MARKET ANALYSIS
    91. GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
    92. GCC COUNTRIES MARKET ANALYSIS BY IMAGING MATERIAL
    93. GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    94. GCC COUNTRIES MARKET ANALYSIS BY END-USERS
    95. SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
    96. SOUTH AFRICA MARKET ANALYSIS BY IMAGING MATERIAL
    97. SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    98. SOUTH AFRICA MARKET ANALYSIS BY END-USERS
    99. REST OF MEA MARKET ANALYSIS BY TEST TYPE
    100. REST OF MEA MARKET ANALYSIS BY IMAGING MATERIAL
    101. REST OF MEA MARKET ANALYSIS BY APPLICATION
    102. REST OF MEA MARKET ANALYSIS BY END-USERS
    103. KEY BUYING CRITERIA OF HEALTHCARE
    104. RESEARCH PROCESS OF MRFR
    105. DRO ANALYSIS OF HEALTHCARE
    106. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. SUPPLY / VALUE CHAIN: HEALTHCARE
    109. HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
    110. HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion)
    111. HEALTHCARE, BY IMAGING MATERIAL, 2024 (% SHARE)
    112. HEALTHCARE, BY IMAGING MATERIAL, 2024 TO 2035 (USD Billion)
    113. HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    114. HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    115. HEALTHCARE, BY END-USERS, 2024 (% SHARE)
    116. HEALTHCARE, BY END-USERS, 2024 TO 2035 (USD Billion)
    117. BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. LIST OF ASSUMPTIONS
    2. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    3. US MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    4. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    5. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    6. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    7. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    8. France MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    9. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    10. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    11. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    12. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    13. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    14. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    15. India MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    16. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    17. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    18. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    19. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    20. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    21. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    22. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    23. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    24. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    25. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    26. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    27. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    28. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    29. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    30. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TEST TYPE, 2025-2035 (USD Billion)
      2. BY IMAGING MATERIAL, 2025-2035 (USD Billion)
      3. BY APPLICATION, 2025-2035 (USD Billion)
      4. BY END-USERS, 2025-2035 (USD Billion)
    31. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    32. ACQUISITION/PARTNERSHIP

Upper Gastrointestinal (GI) Series Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions